Glycolysis-mediated H3K18la modifications drive aggressive bladder cancer through metabolic and epigenetic reprogramming - Top-Institutions - MDSpire

Glycolysis-mediated H3K18la modifications drive aggressive bladder cancer through metabolic and epigenetic reprogramming

  • By

  • Zhan Wang

  • Zhaokai Zhou

  • Shuai Yang

  • Zihao Zhao

  • Xiaozu Li

  • Xingchen Liu

  • Guangyang Cheng

  • Ran Xu

  • Qi Li

  • Dong Xing

  • June 30, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology
    • Urology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology
    • Urology

Original Source(s)

Glycolysis-mediated H3K18la modifications drive aggressive bladder cancer through metabolic and epigenetic reprogramming

  • by Zhan Wang, Zhaokai Zhou, Shuai Yang, Zihao Zhao, Xiaozu Li, Xingchen Liu, Guangyang Cheng, Ran Xu, Qi Li, Dong Xing

  • June 30, 2026

Related Content

Therapeutic inhibition of RAS in non-small cell lung cancer

Alectinib combined with 5-aminolevulinic acid-based photodynamic therapy promotes apoptosis in endometrial cancer cells by targeting ferrochelatase

Artificial intelligence for triple-negative breast cancer from imaging to multi-omics